Trials / Unknown
UnknownNCT05105997
Dexamethasone/ Erector Spinae Plane Block Analgesia in Laparoscopic Cholecystectomy
Dexamethasone as a Bupivacaine Adjuvant in Ultrasound-guided Erector Spinae Plane Block for Patients Undergoing Laparoscopic Cholecystectomy: a Randomized Double-blind Study
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Although considered a minimally invasive procedure, laparoscopic cholecystectomy (LC) frequently results in moderate to severe immediate postoperative pain.
Detailed description
Although considered a minimally invasive procedure, laparoscopic cholecystectomy (LC) frequently results in moderate to severe immediate postoperative pain. In addition to predominant visceral pain, nearly half of all patients suffer from shoulder pain in the early postoperative period. The most likely reason is sub-diaphragmatic irritation, which is transmitted by the phrenic nerve, causing referred pain in the C4 dermatome. Due to multiple sources of pain, multimodal analgesia approaches have been used in the perioperative period following LC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone/ Erector Spinae Plane Block | Patients will receive bilateral Ultrasound-guided Erector Spinae Plane Block with bupivacaine and dexamethasone 15 minutes before skin incision |
| DRUG | Erector Spinae Plane Block | Patients will receive bilateral Ultrasound-guided Erector Spinae Plane Block with bupivacaine and one ml of normal saline 15 minutes before skin incision. |
Timeline
- Start date
- 2022-12-01
- Primary completion
- 2023-07-01
- Completion
- 2023-07-01
- First posted
- 2021-11-03
- Last updated
- 2022-09-23
Source: ClinicalTrials.gov record NCT05105997. Inclusion in this directory is not an endorsement.